“…Bowel function and quality of life before and after surgery were investigated by means of two validated questionnaires: the Gastrointestinal Quality of Life (GIQLI) questionnaire, which was administered to all patients with inflammatory, ischemic, or neoplastic disease, and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-CR29 modules, which were selectively administered only to patients with neoplastic disease [12][13][14]. The GIQLI questionnaire was filled out by patients at the time of surgery, 2 weeks after surgery, and 6 weeks after surgery, evaluating the following selected items: abdominal pain, bloating, bowel frequency, bowel urgency, bowel movement, diarrhea, constipation, and nausea (i.e., question numbers 1, 3,7,30,31,32,33,36).…”